why choose us

First received: January 15, 2024

Clinical Trial: A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL


Official Title: A Two-part, Single Center, Open-label Study to Investigate the Pharmacokinetics, Metabolic Disposition, Mass Balance and Absolute Bioavailability of BAY 2927088 in Healthy Male Participants

Brief Summary: Researchers are looking for a better way to treat men who have advanced non-small cell lung cancer (NSCLC).NSCLC is a group of lung cancers that have spread to nearby tissues or to other parts of the body.Epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) are proteins that help cells to grow and divide.A damage (also called mutation) to the building plans (genes) for these proteins in cancer cells leads to a production of abnormal EGFR and/or HER2.These abnormal…

Read more